Similarly, rhodopsin, a compound extracted from certain plants, curtails the transcriptional prowess of SREBP‐2, interferes with cholesterol synthesis, and dampens the Akt pathways, thereby heightening the vulnerability of HCC cells to the tumor‐fighting properties of sorafenib in both lab cultures and animal studies [241]. The gene discussed is SREBF2; the disease is hepatocellular carcinoma.